Want to see GB:OXB full AI Analyst Report?
Oxford BioMedica (OXB) Ownership - Who Owns Oxford BioMedica?
Oxford BioMedica (OXB) Ownership Overview
- 0.38% Insiders
- 0.08% Mutual Funds
- 1.88% Other Institutional Investors
- 2.60% ETFs
- 95.06% Public Companies and Individual Investors
The ownership structure of Oxford BioMedica (GB:OXB) stock is a mix of institutional, retail, and individual investors. Approximately 4.56% of the company’s stock is owned by Institutional Investors, 0.38% is owned by Insiders, and 95.06% is owned by Public Companies and Individual Investors.
The ownership structure of Oxford BioMedica (GB:OXB) stock is a mix of institutional, retail, and individual investors. Approximately 4.56% of the company’s stock is owned by Institutional Investors, 0.38% is owned by Insiders, and 95.06% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Oct 05, 2026 | Kathleen Miller | £6,440 | |
| Sep 27, 2026 | Peter Soelkner | €9,963 | |
| Sep 24, 2026 | Peter Soelkner | €10,012 | |
| Sep 23, 2026 | Frederic Roch Doliveux | £102,263 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 1,341,463 | Institution | 1.11% | 9,678,656 |
| Vanguard | 1,106,396 | Institution | 0.91% | 7,982,647 |
| Frederic Roch Doliveux | 459,055 | Insider | 0.38% | 3,312,082 |
| Ubs | 190,100 | Institution | 0.16% | 1,371,572 |
| Xtrackers | 182,337 | Institution | 0.15% | 1,315,561 |
| Amundi | 168,750 | Institution | 0.14% | 1,217,531 |
| Spdr | 86,178 | Institution | 0.07% | 621,774 |
| State Street | 50,476 | Institution | 0.04% | 364,184 |
| Fidelity Salem Street Trust | 50,034 | Institution | 0.04% | 360,995 |
| Fidelity Concord Street Trust | 21,313 | Institution | 0.02% | 153,773 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Salem Street Trust | 50,034 | Institution | 0.04% | 360,995 |
| Fidelity Concord Street Trust | 21,313 | Institution | 0.02% | 153,773 |
| State Street Institutional Investment Trust | 20,000 | Institution | 0.02% | 144,300 |
| Franklin Alternative Strategies Funds | 1 | Institution | 0.00% | 7 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, DE:VMIG ETF | 553,198 | Institution | 0.46% | 2,887,694 |
| Vanguard, GB:VMID ETF | 553,198 | Institution | 0.46% | 2,887,694 |
| iShares, IEFA ETF | 549,357 | Institution | 0.45% | 3,966,158 |
| iShares, SCZ ETF | 278,341 | Institution | 0.23% | 2,009,521 |
| Xtrackers, GB:XXSC ETF | 174,761 | Institution | 0.14% | 1,243,373 |
| Amundi, GB:PRUK ETF | 149,480 | Institution | 0.12% | 799,718 |
| iShares, IEUR ETF | 52,615 | Institution | 0.04% | 379,861 |
| State Street, GWX ETF | 48,157 | Institution | 0.04% | 342,623 |
| UBS, DE:4UB5 ETF | 47,465 | Institution | 0.04% | 252,514 |
| UBS, GB:0Y7Z ETF | 47,465 | Institution | 0.04% | 252,514 |
FAQ
Who Owns Oxford BioMedica (GB:OXB)?
According to the latest TipRanks data, approximately 4.56% of the company's stock is held by institutional investors, 0.38% is held by insiders, and 95.06% is held by public companies and individual investors.
What percentage of Oxford BioMedica (GB:OXB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.56% of Oxford BioMedica (GB:OXB) stock is held by institutional investors: 0.08% by mutual funds, 2.60% by ETFs and 1.88% by other institutional investors.
What percentage of Oxford BioMedica (GB:OXB) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.06% of Oxford BioMedica (GB:OXB) stock is held by public companies and individual investors.
Who owns the most shares of Oxford BioMedica (GB:OXB)?
iShares owns the most shares of Oxford BioMedica (GB:OXB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
